Curcumin References

1. Sinha R, Anderson DE, McDonald SS, Greenwald P. "Cancer risk and diet in India." J Postgrad Med. 2003 Jul-Sep;49(3):222-228.
2. Shim JS, Kim JH, Cho HY, Yum YN, Kim SH, Park HJ, Shim BS, Choi SH, Kwon HJ. "Irreversible inhibition of CD13/aminopeptidase N by the antiangiogenic agent Curcumin." Chem Biol. 2003 Aug;10(8):695-704.
3. Aggarwal BB, Kumar A, Bharti AC. "Anticancer potential of Curcumin: preclinical and clinical studies." Anticancer Res. 2003 Jan-Feb;23(1A):363-98.
4. Cheng Y, Li HL, Wang HF, Sun HF, Liu YF, Peng SX, Liu KX, Guo ZY. "Inhibition of nicotine-DNA adduct formation in mice by six dietary constituents." Food Chem Toxicol. 2003 Jul;41(7):1045-50. Online
5. Chen YS, Ho CC, Cheng KC, Tyan YS, Hung CF, Tan TW, Chung JG. "Curcumin inhibited the arylamines N-acetyltransferase activity, gene expression and DNA adduct formation in human lung cancer cells (A549)." Toxicol In Vitro. 2003 Jun;17(3):323-33.
6. Corpet DE, Pierre F Point: From animal models to prevention of colon cancer. Systematic review of chemoprevention in min mice and choice of the model system. Cancer Epidemiol Biomarkers Prev. 2003 May;12(5):401-4.
7. Vietri M, Pietrabissa A, Mosca F, Spisni R, Pacifici GM. "Curcumin is a potent inhibitor of phenol sulfotransferase (SULT1A1) in human liver and extrahepatic tissues." Xenobiotica. 2003 Apr;33(4):357-63.
8. "Prostate Cancer." Mayo Clinic. Online
9. Chaudhary LR, Hruska KA. "Inhibition of cell survival signal protein kinase B/Akt by Curcumin in human prostate cancer cells." J Cell Biochem. 2003 May 1;89(1):1-5.
10. Deeb D, Xu YX, Jiang H, Gao X, Janakiraman N, Chapman RA, Gautam SC. "Curcumin (diferuloyl-methane) enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in LNCaP prostate cancer cells." Mol Cancer Ther. 2003 Jan;2(1):95-103.
11. Dorai T, Gehani N, Katz A. "Therapeutic potential of Curcumin in human prostate cancer-I. Curcumin induces apoptosis in both androgen-dependent and androgen-independent prostate cancer cells." Prostate Cancer Prostatic Dis. 2000 Aug;3(2):84-93.
12. Ishida J, Ohtsu H, Tachibana Y, Nakanishi Y, Bastow KF, Nagai M, Wang HK, Itokawa H, Lee KH. "Antitumor agents. Part 214: synthesis and evaluation of curcumin analogues as cytotoxic agents." Bioorg Med Chem. 2002 Nov;10(11):3481-7.
13. Shao ZM, Shen ZZ, Liu CH, Sartippour MR, Go VL, Heber D, Nguyen M. "Curcumin exerts multiple suppressive effects on human breast carcinoma cells." Int J Cancer. 2002 Mar 10;98(2):234-40.
14. Chauhan DP. "Chemotherapeutic potential of Curcumin for colorectal cancer." Curr Pharm Des. 2002;8(19):1695-706
15. Reddy BS, Rao CV. "Novel approaches for colon cancer prevention by cyclooxygenase-2 inhibitors." J Environ Pathol Toxicol Oncol. 2002;21(2):155-64.
16. Venkatesan N, Punithavathi D, Arumugam V. "Curcumin prevents adriamycin nephrotoxicity in rats." Br J Pharmacol. 2000 Jan;129(2):231-4.
17. Park SY, Kim DS. "Discovery of natural products from Curcuma longa that protect cells from beta-amyloid insult: a drug discovery effort against Alzheimer's disease." J Nat Prod. 2002 Sep;65(9):1227-31.
18. Frautschy SA, Hu W, Kim P, Miller SA, Chu T, Harris-White ME, Cole GM. "Phenolic anti-inflammatory antioxidant reversal of Abeta-induced cognitive deficits and neuropathology." Neurobiol Aging. 2001 Nov-Dec;22(6):993-1005.
19. Lim GP, Chu T, Yang F, Beech W, Frautschy SA, Cole GM. "The curry spice Curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse." J Neurosci. 2001 Nov 1;21(21):8370-7.
20. Vlietinck AJ, De Bruyne T, Apers S, Pieters LA.Plant-derived leading compounds for chemotherapy of human immunodeficiency virus (HIV) infection. Planta Med. 1998 Mar;64(2):97-109.
21. Jordan WC, Drew CR. "Curcumin--a natural herb with anti-HIV activity." J Natl Med Assoc. 1996 Jun;88(6):333.
22. Mazumder A, Raghavan K, Weinstein J, Kohn KW, Pommier Y. "Inhibition of human immunodeficiency virus type-1 integrase by Curcumin." Biochem Pharmacol. 1995 Apr 18;49(8):1165-70.
23. Niederau C, Gopfert E. "The effect of chelidonium- and turmeric root extract on upper abdominal pain due to functional disorders of the biliary system. Results from a placebo-controlled double-blind study" Med Klin (Munich). 1999 Aug 15;94(8):425-30.
24. Awasthi S, Srivatava SK, Piper JT, Singhal SS, Chaubey M, Awasthi YC. "Curcumin protects against 4-hydroxy-2-trans-nonenal-induced cataract formation in rat lenses." Am J Clin Nutr. 1996 Nov;64(5):761-6.
25. Rithaporn T, Monga M, Rajasekaran M. "Curcumin: a potential vaginal contraceptive." Contraception. 2003 Sep;68(3):219-23.
26. Natarajan C, Bright JJ. "Curcumin inhibits experimental allergic encephalomyelitis by blocking IL-12 signaling through Janus kinase-STAT pathway in T lymphocytes." J Immunol. 2002 Jun 15;168(12):6506-13.
27. Banerjee M, Tripathi LM, Srivastava VM, Puri A, Shukla R. "Modulation of inflammatory mediators by ibuprofen and curcumin treatment during chronic inflammation in rat." Immunopharmacol Immunotoxicol. 2003 May;25(2):213-24.
28. Kandarkar SV, Sawant SS, Ingle AD, et al. Subchronic oral hepatotoxicity of turmeric in mice--histopathological and ultrastructural studies. Indian J Exp Biol. 1998 Jul;36(7):675-679.
29. Babu PS, et al. Hypolipidemic action of curcumin, the active principle of turmeric (Curcuma longa) in streptozocin induced diabetic rats. Mol Cell Biochem. 1997;166:169-175.
30. Aggarwal BB, Kumar A, Bharti AC. "Anticancer potential of Curcumin: preclinical and clinical studies." Anticancer Res. 2003 Jan-Feb;23(1A):363-98.
31. Chainani-Wu N. "Safety and anti-inflammatory activity of Curcumin: a component of tumeric (Curcuma longa)." J Altern Complement Med. 2003 Feb;9(1):161-8.
32. Soni KB, Kuttan R. Effect of oral curcumin administration on serum peroxides and cholesterol levels in human volunteers. Indian J Physiol Pharmacol. 1992 Oct;36(4):273-5.
33. Ramirez-Tortosa MC, Mesa MD, et.al., Oral administration of turmeric extract inhibits LDL oxidation and has hypocholesterolemic effects in rabbits with experimental atherosclerosis. Indian J Physiol Pharmacol. 1999 Dec; 147 (2):371-8.
34. Ramirez-Bosca A, Soler A, et.al., An hydroalcoholic extract of curcuma longa lowers the apo B/apo A ratio - Implications for atherogenesis prevention.